Patent ID: 7431924

Claim:
A method for treating inflammation, which is mediated by chemoattraction of peripheral blood monocytes or T-cells, in a subject comprising administering, to said subject, an effective dose of an isolated antibody or antigen-binding fragment thereof, or a pharmaceutical composition thereof comprising said antibody or antigen-binding fragment and a pharmaceutically acceptable carrier, which antibody or antigen-binding fragment specifically binds to a polypeptide wherein said polypeptide a) chemoattracts peripheral blood monocytes or T-cells, b) consists of an amino acid sequence comprising at least 95% sequence identity to residues 25 to 395 of the amino acid sequence set forth in SEQ ID NO: 8, and c) comprises a chemokine domain identical to residues 25 to 100 of the amino acid sequence set forth in SEQ ID NO: 8.